Smith+Nephew Unveils Cutting-edge AI Robotic Solutions at AAOS 2024

Smith+Nephew LSE: SN, NYSE: SNN, a leading global medical technology company, is set to present its state-of-the-art AI-based robotic systems designed for personalized orthopaedic surgeries at the forthcoming AAOS 2024 Annual Meeting. With the industry's attention focused on the advancements in surgical technologies, Smith+Nephew is introducing a pioneering feature for its widely recognized CORI◊ Surgical System. This system represents a breakthrough in robotic-assisted surgeries, boasting an image-agnostic* capability that distinguishes it within the medical tech space.

Revolutionizing Orthopaedic Surgery with AI and Robotics

Robotics and artificial intelligence are rapidly changing the face of medicine, and orthopaedic surgery is no exception. The CORI◊ Surgical System, developed by Smith+Nephew, is at the forefront of these innovations. It allows orthopaedic surgeons to deliver highly personalized surgical procedures that are tailored to individual patient anatomy and needs. By showcasing the latest enhancements to the CORI◊ system at AAOS 2024, Smith+Nephew is demonstrating its commitment to improving surgical outcomes through advanced technology.

A Look into the Future of Medical Tech

Investors and medical professionals alike are keen to observe the potential impact of Smith+Nephew's technologies on the industry. The AAOS Annual Meeting will serve as a prime venue for revealing the capabilities of the new feature set to roll out for the CORI◊ system. This event will not only be an opportunity to understand how image-agnostic* robotics can integrate into surgical workflows, but also how Smith+Nephew's innovations reinforce its positioning in the marketplace as a forward-thinking medical device company.

innovation, technology, orthopaedics